Business Description
Mithra Pharmaceuticals SA
ISIN : BE0974283153
Compare
Compare
Traded in other countries / regions
MITRA.BelgiumMITPF.USA1TM.Germany0R91.UK IPO Date
2015-07-06Description
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 40.39 | |||||
| 14-Day RSI | 38.94 | |||||
| 6-1 Month Momentum % | -31.94 | |||||
| 12-1 Month Momentum % | -90.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -45.22 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 2.4 | |||||
| EV-to-Forward-EBIT | 5.43 | |||||
| EV-to-Forward-EBITDA | 4.04 | |||||
| EV-to-Forward-Revenue | 1.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mithra Pharmaceuticals SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 62.675 | ||
| EPS (TTM) (€) | -1.41 | ||
| Beta | 0 | ||
| Volatility % | 75.26 | ||
| 14-Day RSI | 38.94 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.1756 | ||
| 12-1 Month Momentum % | -90.03 | ||
| 52-Week Range (€) | 0.1636 - 1.618 | ||
| Shares Outstanding (Mil) | 66.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mithra Pharmaceuticals SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mithra Pharmaceuticals SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mithra Pharmaceuticals SA Frequently Asked Questions
What is Mithra Pharmaceuticals SA(FRA:1TM)'s stock price today?
The current price of FRA:1TM is €0.18. The 52 week high of FRA:1TM is €1.62 and 52 week low is €0.16.
When is next earnings date of Mithra Pharmaceuticals SA(FRA:1TM)?
The next earnings date of Mithra Pharmaceuticals SA(FRA:1TM) is 2025-03-07 Est..
Does Mithra Pharmaceuticals SA(FRA:1TM) pay dividends? If so, how much?
Mithra Pharmaceuticals SA(FRA:1TM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers